Inflammation, glucose metabolism, and nutritional markers in relation to all-cause and cardiac mortality among initial hemodialysis patients: a multicenter cohort study

作者：Shi‐mei Hou, Yuting Gao, Menghuan Wu, Yu-xin Ren, Jing Zheng, Yao Wang, Jingyuan Cao, Xiaoxu Wang, Yang Yan, Bin Wang, Min Yang, Min Li · 发表于：Frontiers in Nutrition · 年份：2025 · DOI：10.3389/fnut.2025.1660267 · 被引用次数：2 · 研究领域：Dialysis and Renal Disease Management、Parathyroid Disorders and Treatments、Inflammatory Biomarkers in Disease Prognosis

Objective To investigate the prognostic value of inflammatory biomarkers including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR), glucose metabolism (glucose-to-lymphocyte ratio, GLR), and nutritional (albumin, ALB) biomarkers for predicting all-cause and cardiac mortality in patients initiating hemodialysis (HD), and evaluates their incremental value when integrated into traditional risk models. Methods A retrospective cohort of 795 initial HD patients (2014–2020) was analyzed, with follow-up through 2022. Cox proportional hazards models were used to assess associations between biomarkers and mortality. Predictive performance was evaluated using time-dependent ROC curves, C-index, net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Patients were randomly assigned to training ( n = 557) and validation ( n = 238) sets, and a survival nomogram was developed based on a full-risk model incorporating both traditional and biomarker variables. Results Elevated NLR, PLR, and GLR were independently associated with increased all-cause and cardiac mortality, whereas lower LMR and ALB were protective (all p < 0.05). NLR exhibited the highest predictive accuracy across 1-, 3-, and 5-year intervals, followed by GLR and PLR. The full-risk model significantly outperformed the baseline model, with AUCs up to 0.980 and 0.966 for all-cause mortality and 0.947 and 0.978 for cardiac mort...